![]() |
![]() |
![]() |
![]() |
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | FDA Centennial
FOR IMMEDIATE RELEASE |
Media
Inquiries: |
The Food and Drug Administration (FDA) today announced plans to hold a public hearing to solicit comments and information on the electronic submission of product information. The Agency is also interested in hearing the public's perspectives on issues related to creating an electronic information exchange platform. Information provided at the hearing will help FDA shape a modern paperless submission process and help facilitate the effective use of submitted information, including drug safety information.
"The FDA sits on the world's singular repository of drug safety and effectiveness information, but so long as a lot of it remains locked away in paper archives, it is hard for us to explore ways to leverage this knowledge while protecting confidential commercial information," said Dr. Scott Gottlieb, FDA's Deputy Commissioner for Scientific and Medical Affairs. "Receiving information in a consistent electronic format would help FDA make more effective use of important drug information especially in safety situations."
Today's announcement follows numerous steps taken by the agency over the past ten years to transform all regulatory submissions from paper to electronic means. To meet this goal, FDA has issued regulations enabling voluntary electronic submission of regulatory information; provided a docket listing all submissions that the agency accepts electronically; and issued guidance documents to assist in the submission of various regulatory documents in electronic format.
The scope of the upcoming hearing will include the following issues related to an all-electronic environment.
Additional details about the hearing and specific questions to be addressed by participants are available at http://www.fda.gov/OHRMS/DOCKETS/98fr/oc06266.pdf.
The hearing is scheduled to be held from 9 a.m. to 5 p.m. on December 18, 2006, at the Advisors and Consultants Staff Conference Room, Food and Drug Administration, 5630 Fishers Lane, Rockville, MD 20857. Registration on the day of the public hearing will be provided on a space available basis beginning at 7:30 a.m. Information on parking and public transportation may be accessed at http://www.fda.gov/oc/initiatives/criticalpath/.
Interested individuals are encouraged to submit notices of participation and comments by December 8, 2006, either in writing to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20857, or electronically to http://www.accessdata.fda.gov/scripts/oc/dockets/commentdockets.cfm. For additional information, please contact Paula S. McKeever, Office of Critical Path Programs (HF-18), Food and Drug Administration, 5600 Fishers Lane, rm. 14B-45, Rockville, MD 20857, 301-827-1520, paula.mckeever@fda.hhs.gov.
####
RSS Feed for FDA News Releases [what's this?]
Get
free weekly updates about FDA press releases, recalls, speeches, testimony
and more.